Melgar, Cresencia S.

HRN: 18-31-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2022
CEFTRIAXONE 1G (VIAL)
11/05/2022
11/12/2022
IV
2g
OD
UTI
Waiting Final Action 
11/08/2022
CIPROFLOXACIN 500MG (TAB)
11/08/2022
11/15/2022
PO
500mg
BID
Acute Pyelonephritis; T/C Adverse Drug Reaction To Ceftri
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: